What is the difference between CJC-1295 and sermorelin?

Both are GHRH analogues, but CJC-1295 is a modified version with greater stability. Sermorelin is a 29-amino acid fragment of GHRH with a short half-life (~10 minutes). CJC-1295 without DAC has a similar half-life. CJC-1295 with DAC has a half-life of 6–8 days due to albumin binding.

Which produces more GH — CJC-1295 or sermorelin?

CJC-1295 (especially with DAC) produces more sustained GH elevation than sermorelin due to its longer half-life. CJC-1295 without DAC is roughly equivalent to sermorelin in terms of GH pulse magnitude. For pulsatile GH release, CJC-1295 without DAC and sermorelin are comparable.

Should I use CJC-1295 with DAC or without DAC?

CJC-1295 without DAC (Mod GRF 1-29) produces pulsatile GH release and is injected 2–3 times daily. CJC-1295 with DAC produces sustained GH elevation and is injected once or twice weekly. Most researchers prefer without DAC for its more physiological pulsatile pattern when combined with ipamorelin.

Can CJC-1295 and sermorelin be used together?

Using both simultaneously is not typically done as they work through the same receptor (GHRH-R) and would compete. Most researchers choose one GHRH analogue and combine it with a ghrelin mimetic (ipamorelin) for synergistic dual-pathway GH stimulation.

Which is better for beginners — CJC-1295 or sermorelin?

Sermorelin is often recommended for beginners due to its longer clinical history and more conservative GH stimulation. CJC-1295 without DAC is a close equivalent. CJC-1295 with DAC is generally reserved for more advanced protocols due to its sustained GH elevation.

✦Use code HEALTH for 20% off at Purgo Labs✦

Head-to-Head Comparison

CJC-1295 vs Sermorelin

Head-to-head comparison of CJC-1295 (no DAC) and Sermorelin for GH optimization, sleep, and recovery. Which GHRH analog is more effective?

What the cited studies used

One row per compound: the amount and schedule administered in a specific indexed study, who received it, and the paper. These are reports of what was done in that study, not recommendations, and several are animal or single-dose studies. Where no indexed human regimen exists we say so rather than print a number. Community "stacks" and cycle schedules are not reproduced on this site.

Research use only. Compound Review scores vendors on documentation — laboratory certificates, lot records, pricing and company identity. Nothing on this page is guidance on human or veterinary use, dosing or health outcomes.

Compound	Regimen in the study	Population	Source
CJC-1295 (with DAC)	Single subcutaneous doses of 30, 60, 90 or 125 µg/kg; repeated 30 or 60 µg/kg weekly or every two weeks This is the DAC form with a multi-day half-life, not 'CJC-1295 no DAC' (mod GRF 1-29), for which we hold no human dose trial.	Healthy adults (two randomised, placebo-controlled studies)	PMID 16352683 Teichman et al., J Clin Endocrinol Metab 2006
Sermorelin (GHRH 1-29)	2 mg subcutaneous, once nightly at bedtime, for 6 weeks	Eleven healthy men aged 64–76 with low baseline IGF-I	PMID 9005976 Vittone et al., Metabolism 1997

CJC-1295 (no DAC) and Sermorelin are both GHRH analogs — they mimic growth hormone-releasing hormone to stimulate the pituitary. CJC-1295 is a modified version of Sermorelin with a longer half-life and stronger GH response. Understanding the differences helps researchers choose the right GHRH analog for their protocol.

Our Verdict

Winner: CJC-1295 (no DAC)

CJC-1295 (no DAC) is generally the stronger choice — it produces a larger GH pulse than Sermorelin due to its modified amino acid sequence that resists enzymatic degradation. However, Sermorelin is more physiological and may be preferable for long-term GH axis health. For most researchers, CJC-1295 stacked with Ipamorelin is the gold standard GH secretagogue combination.

Pathway Comparison Diagram

CJC-1295's DAC modification produces sustained flat GH elevation over days; Sermorelin's short half-life generates physiological pulsatile spikes — the core tradeoff visualized.

CJC-1295 vs Sermorelin mechanism comparison diagram showing sustained GH elevation vs pulsatile GH release with GH release timeline graphs

CJC-1295 vs Sermorelin: Side-by-Side

Category	CJC-1295	Sermorelin
Type	Modified GHRH analog (Mod GRF 1-29)	Natural GHRH analog (GHRH 1-29)
Half-life	~30 minutes	~10–20 minutes
GH Response	Stronger — modified sequence resists degradation	Moderate — natural sequence, faster clearance
Physiological	Slightly modified	Most physiological GHRH analog
Typical Dose	See "What the cited studies used"	See "What the cited studies used"
Stacking	Excellent with Ipamorelin	Excellent with Ipamorelin
Long-term Safety	Good, limited long-term data	Good, more established track record
Cost	Similar	Similar

Source Both Peptides at Purgo Labs

Purgo Labs carries pharmaceutical-grade CJC-1295 and Sermorelin with third-party COAs. Use code HEALTH for 20% off.

Visit Purgo Labs

Frequently Asked Questions

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 without DAC (Mod GRF 1-29) has a ~30-minute half-life and produces a pulsatile GH release. CJC-1295 with DAC has a ~8-day half-life and produces sustained GH elevation. The no-DAC version is preferred for mimicking natural GH pulsatility and is safer for long-term use.

Is CJC-1295 stronger than Sermorelin?

Yes — CJC-1295 (no DAC) produces a larger GH pulse than Sermorelin because its modified amino acid sequence resists enzymatic degradation, allowing more of the peptide to reach the pituitary receptors.

Which should I stack with Ipamorelin: CJC-1295 or Sermorelin?

Both work well with Ipamorelin. CJC-1295 is slightly more potent; Sermorelin is more physiological. CJC-1295/Ipamorelin is the most commonly reported stack in the research community.